A new nasal spray developed by Texas A&M researchers offers insights into treating age-related cognitive decline through three key mechanisms. First, the nasal delivery system directly accesses the brain via olfactory pathways, bypassing the blood-brain barrier to minimize systemic side effects while maximizing therapeutic efficacy. Second, the treatment targets specific inflammatory cascades that contribute to cognitive aging, with preclinical evidence demonstrating restored brain energy metabolism essential for learning and memory. Third, cognitive benefits persisted for months following brief treatment, suggesting durable effects from targeting fundamental neuroinflammatory pathways. These findings indicate that anti-inflammatory approaches may address root causes of age-related cognitive changes rather than merely managing symptoms. While human trials are essential before clinical application, this research establishes a promising framework for future interventions targeting neuroinflammation in aging populations. Read the full article on GMJ Newsroom.
Was this article helpful?
